MedTrace Logo

The Effect of Adaptogen Elixir on Sleep Improvement

NCT06279312 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2025-04-11

No results posted yet for this study

Summary

This study aims to examine the effectiveness of Adaptogen Elixir herbal drink in relieving emotions and improving sleep quality. Participants will be randomly assigned to either the placebo group or the Adaptogen Elixir herbal drink group, with 25 participants in each group. On the day of the experiment (week 0), participants are required to collect blood and saliva samples, fill out questionnaires assessing sleep disorders and stress condition, and use a sleep monitoring system to track their sleep and autonomic nervous system conditions. Subsequently, participants will be given the experimental samples and instructed to consume them continuously for 4 weeks following the instruction. Follow-up assessments will be conducted in the 2nd and 4th weeks, participants are required to collect blood and saliva samples, fill out questionnaires assessing sleep disorders and stress condition, and use a sleep monitoring system to track their sleep and autonomic nervous system conditions.

Conditions

  • Sleep Disorder
  • Anxiety Disorders

Interventions

DIETARY_SUPPLEMENT

Placebo drink

consume 1 drink per day for 4 weeks

DIETARY_SUPPLEMENT

Adaptogen Elixir drink

consume 1 drink per day for 4 weeks

Sponsors & Collaborators

  • TCI Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Hsin-Chien Lee, Doctor · Taipei Medical University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-26
Primary Completion
2024-07-31
Completion
2025-04-01

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06279312 on ClinicalTrials.gov